Author:
El-Zahry Marwa R.,Ibrahim Rania S.,El-Wadood Hanaa M. Abd,Mohamed Horria A.
Abstract
AbstractHerein, a turn “Off/On” fluorescence probe based on ZnO quantum dots (ZnO-QDs) has been proposed and successfully utilized for the determination of Ara-C (cytarabine) using ceric ions (Ce4+) as quencher and ethylenediamine (ED) as a linker. The probe is based initially on the quenching effect of Ce4+ ions on the strong native fluorescence of ZnO-QDs forming the Turn Off system (Ce@ZnO-QDs) that believed to occur due to the aggregation-induced quenching (AIQ) mechanism. The second step is the addition of Ara-C in the presence of ethylenediamine (ED) that encourages the formation of Ara-C/ED/Ce4+ as well as the release of the free ZnO-QDs, leading to the recovery of the fluorescence intensity. The developed sensing platform shows a linear response towards Ara-C over the range of 10 to 1000 ng mL−1 giving a limit of detection (LOD) and limit of quantitation (LOQ) of 1.22 ng mL−1 and 3.70 ng mL−1, respectively. A dispersive magnetic solid phase micro-extraction (dMSPE) method was developed and optimized for the extraction of Ara-C in spiked human plasma using thiol-modified magnetite nanoparticles (S-MNPs). The proposed platform exhibits good sensitivity toward Ara-C in the presence of different interfering substances. Excellent recoveries are obtained after spiking different concentrations of Ara-C into rabbit plasma samples. The validated experimental parameters have been successfully applied to monitor the pharmacokinetic profile of Ara-C in rabbit plasma. A detailed adsorption kinetics study has been carried out to provide a deep insight into the adsorption behavior of Ara-C on the thiol-doped-magnetite nanoparticles. The greenness assessment of the proposed method was achieved and compared with other reported methods using two tools of greenness; the green analytical procedure index (GAPI) and the analytical greenness calculator AGREE.
Publisher
Springer Science and Business Media LLC
Subject
Law,Clinical Biochemistry,Spectroscopy,Sociology and Political Science,Social Sciences (miscellaneous),Clinical Psychology,Biochemistry
Reference52 articles.
1. Momparler RL (2013) Optimization of cytarabine (ARA-C) therapy for acute myeloid Leukemia. Exp Hematol Oncol 2:20–25. https://doi.org/10.1186/2162-3619-2-20
2. Subramanian N, Murthy R (2004) Two simple spectrophotometric methods for the determination of cytarabine and its injectable formulation. Ars Pharm 45:319–334
3. Murthy V, Rohini A, Pravallika K, Prameela Rani A, Rahaman S (2013) Development and validation of a novel UV-Visible spectrophomtric method for cytarabine in bulk and pharmaceutical dosage forms. Der Pharm Lett 5:51–55
4. Montazeralmahdi M, Sheibani A, Shishehbore M (2019) First- and third-derivative spectrophotometry for simultaneous determination of dexamethasone and cytarabine in pharmaceutical formulations and biological fluids. J Appl Spectrosc 86:843–847. https://doi.org/10.1007/s10812-019-00904-3
5. Cai Z, Zhang X, Lu DF, Gan JN (2012) A new chemiluminescence method for determination of cytosine arabinoside in pharmaceutical preparations. Bull Korean Chem Soc 33:171–176. https://doi.org/10.5012/bkcs.2012.33.1.171